Check out our recent publications in MDPI Cells

A recent issue of the MDPI journal Cells, focusing on ‘Molecular Immunology in Bacterial Vaccine Discovery’, featured 7 BactiVax publications, all authored by our Early Stage Researchers (link to the special issue here). Our publications cover the most recent advancements in the discovery and development of vaccines against dangerous, antimicrobial-resistant pathogens. All our papers are freely accessible and can be read following the links below:

• Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development. Samuel Pasco and Juan Anguita. Cells 2020, 9(9), 2109; https://doi.org/10.3390/cells9092109.

• Current Advances in Burkholderia Vaccines Development. Guanbo Wang, Paulina Zarodkiewicz and Miguel A. Valvano. Cells 2020, 9(12), 2671; https://doi.org/10.3390/cells9122671.

• Understanding Pseudomonas aeruginosa–Host Interactions: The Ongoing Quest for an Efficacious Vaccine. Maite Sainz-Mejías, Irene Jurado-Martín and Siobhán McClean. Cells 2020, 9(12), 2617; https://doi.org/10.3390/cells9122617.

• Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis. Chiara Bellini and Kata Horváti. Cells 2020, 9(12), 2673; https://doi.org/10.3390/cells9122673.

• Current Status on Therapeutic Molecules Targeting Siglec Receptors. María Pia Lenza, Unai Atxabal, Iker Oyenarte, Jesús Jiménez-Barbero and June Ereño-Orbea. Cells 2020, 9(12), 2691; https://doi.org/10.3390/cells9122691.

• Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants. Ana Rita Franco and Francesco Peri. Cells 2021, 10(1), 78; https://doi.org/10.3390/cells10010078.

• PE_PGRS33, an Important Virulence Factor of Mycobacterium tuberculosis and Potential Target of Host Humoral Immune Response. Eliza Kramarska, Flavia Squeglia, Flavio De Maio, Giovanni Delogu and Rita Berisio. Cells 2021, 10(1), 161; https://doi.org/10.3390/cells10010161.

Recent tweets from BactiVax

• 
  BactiVax

  RT @mcclean_siobhan: Our fantastic @Bactivax meeting is all over. Great science, great chats and plenty of fun. Thanks to Rita Berisio (… https://t.co/sC7ddNvinE

  Oct 1, 2022, 1:42 PM
• 
  BactiVax

  RT @mcclean_siobhan: We had a really informative session this morning on D3 of our @BactiVax summer school: Science Communication & over… https://t.co/sj3zYNHs0h

  Sep 30, 2022, 4:30 PM

Check us out on Instagram

Congratulations to #BactiVax researchers @irenejm6, @maite_s96 and Assoc. Prof. Siobhán McClean on their recently published review on Pseudomonas aeruginosa #vaccine development! 🦠 P. aeruginosa is an antibiotic-resistant, hospital-acquired pathogen that can cause severe and difficult to treat infections. Link to open access paper here & in bio: https://t.co/l1y9Ugh5Sj?amp=1

🧪⚗ #EuropeanResearchersNight is here! Make sure to check some of the #cool #science events organised across Europe today, especially the @meetmetonight20 event in Milan, as #BactiVax will be there. Tonight @5pm CET & tomorrow @4pm CET, we'll have interactive sessions on #vaccine discovery, held by our Project 6 Researcher @_ritafranco and Prof. Francesco Peri @unimib. 🗒 Free registration: meetmetonight.it/programma/